1. Home
  2. TVTX vs AVDX Comparison

TVTX vs AVDX Comparison

Compare TVTX & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • AVDX
  • Stock Information
  • Founded
  • TVTX 2008
  • AVDX 2000
  • Country
  • TVTX United States
  • AVDX United States
  • Employees
  • TVTX N/A
  • AVDX N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • AVDX EDP Services
  • Sector
  • TVTX Health Care
  • AVDX Technology
  • Exchange
  • TVTX Nasdaq
  • AVDX Nasdaq
  • Market Cap
  • TVTX 1.6B
  • AVDX 1.6B
  • IPO Year
  • TVTX N/A
  • AVDX 2021
  • Fundamental
  • Price
  • TVTX $17.49
  • AVDX $11.21
  • Analyst Decision
  • TVTX Buy
  • AVDX Hold
  • Analyst Count
  • TVTX 13
  • AVDX 15
  • Target Price
  • TVTX $23.46
  • AVDX $11.70
  • AVG Volume (30 Days)
  • TVTX 1.1M
  • AVDX 1.5M
  • Earning Date
  • TVTX 02-13-2025
  • AVDX 11-06-2024
  • Dividend Yield
  • TVTX N/A
  • AVDX N/A
  • EPS Growth
  • TVTX N/A
  • AVDX N/A
  • EPS
  • TVTX N/A
  • AVDX N/A
  • Revenue
  • TVTX $203,447,000.00
  • AVDX $427,566,000.00
  • Revenue This Year
  • TVTX $62.17
  • AVDX $17.55
  • Revenue Next Year
  • TVTX $56.38
  • AVDX $10.57
  • P/E Ratio
  • TVTX N/A
  • AVDX N/A
  • Revenue Growth
  • TVTX 57.08
  • AVDX 17.84
  • 52 Week Low
  • TVTX $5.12
  • AVDX $7.38
  • 52 Week High
  • TVTX $20.33
  • AVDX $13.56
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 39.02
  • AVDX 60.89
  • Support Level
  • TVTX $17.27
  • AVDX $10.85
  • Resistance Level
  • TVTX $19.20
  • AVDX $11.41
  • Average True Range (ATR)
  • TVTX 0.72
  • AVDX 0.27
  • MACD
  • TVTX -0.29
  • AVDX -0.11
  • Stochastic Oscillator
  • TVTX 3.80
  • AVDX 49.40

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About AVDX AvidXchange Holdings Inc.

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

Share on Social Networks: